Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia

3 Likes

It’s a pity it failed phase 3 trials.

2 Likes

Oh thats good, i actually know someone that took roluperidone and he said he found it helpful

3 Likes

I just googled roluperidone. It says it a 5ht2a and sigma2 receptor antagonist. Its a bit strange that antagonizing these receptors would help with negative symptoms.

Very interesting, thank you

2 Likes